Performance of free prostate-specific antigen ratio in differentiating between prostatic cancer and benign prostatic lesions at a referral hospital in South Africa
Background: Prostate cancer is a leading cause of morbidity and mortality in our male population, thus screening initiatives will help to improve outcomes. The current screening marker, total prostate-specific antigen (PSA), is not prostate cancer specific. The development of percentage free PSA (%F...
Saved in:
| Main Authors: | Boitumelo Phiri-Ramongane, Ayeaye Khine |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2018-08-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/4889 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation of expression of Cyclin D1 and E-cadherin with gleason grade, serum prostate specific antigen levels and prostatic volume in prostatic carcinoma
by: C Aatirah, et al.
Published: (2023-07-01) -
Usefulness of prostate specific antigen density in detecting prostate carcinoma: A hospital-based study in patients with prostate biopsies
by: Reshmi Shrestha, et al.
Published: (2022-03-01) -
Male sexuality and the risk of developing benign prostatic hyperplasia and prostate cancer: is there a connection?
by: M. I. Kogan, et al.
Published: (2025-07-01) -
Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: The results of a Delphi consensus project
by: Andrea Cocci, et al.
Published: (2024-04-01) -
DIAGNOSTIC VALUE OF DEFINITION OF FRACTIONS OF PROSTATIC SPECIFIC ANTIGEN AND PROSTATE HEALTH INDEX
by: A. S. Al-Shukri, et al.
Published: (2017-04-01)